APOL1 Testing for Kidney Disease Risk
APOL1 Genotyping CTA Clinical Performance Study
Recruiting
N/A
Interventional Study
APOL1-mediated Kidney Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 2,000 (estimated)
- Sponsor
- Almac Diagnostic Services LLC · Industry
Who this trial is looking for
This trial is looking for people who may be at risk for kidney disease. Participants will have a blood test to check for specific genetic markers related to kidney disease and, if eligible, may join a trial for a new treatment.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been identified by my doctor as a potential candidate for the trial.
- I have signed the Informed Consent Form for the trial.
- My blood specimen is sent to the test site with the correct paperwork.
- My blood specimen meets all requirements for testing.
You may not be able to join if
- My doctor has not identified me as a candidate for the trial.
- I have not signed the Informed Consent Form.
- My blood specimen was sent without the complete Test Request Form.
- My blood specimen does not meet the requirements for testing.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Clinical Performance Study SP2024001, is a prospective, interventional study to assess the clinical performance of the APOL1 Genotyping Clinical Trial Assay (CTA) in the intended use population and environment. The study will use the APOL1 Genotyping CTA to test deoxyribonucleic acid (DNA) extracted from blood specimens to identify individuals who are homozygous or compound heterozygous for apolip…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Study participants must be identified as a potential candidate for the pharmaceutical company- sponsored clinical trial by their physician based on the clinical trial inclusion criteria.
* Study participant has agreed to and signed the clinical trial Informed Consent Form (inc…
Contacts